Remission of symptoms in carcinoid syndrome with a new 5-hydroxytryptamine M receptor antagonist.

Podobne zapisy

• Carcinoid Tumour and 5-Hydroxytryptamine
  od: Graham-Evans, J. N.
  Wydane: (1960)
• In vivo and in vitro activity of selective 5-hydroxytryptamine2 receptor antagonists.
  od: Conolan, S., i wsp.
  Wydane: (1986)
• The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694.
  od: Bermudez, J., i wsp.
  Wydane: (1988)
• Influence of 5-hydroxytryptamine uptake on the apparent 5-hydroxytryptamine antagonist potency of metoclopramide in the rat isolated superior cervical ganglion.
  od: Ireland, S. J., i wsp.
  Wydane: (1987)
• Controlling the carcinoid syndrome.
  od: Hodgson, H. J.
  Wydane: (1988)